Theratechnologies Future Growth
Future criteria checks 4/6
Theratechnologies is forecast to grow earnings and revenue by 57.7% and 7.9% per annum respectively while EPS is expected to grow by 57.5% per annum.
Key information
57.7%
Earnings growth rate
57.5%
EPS growth rate
| Biotechs earnings growth | 43.0% |
| Revenue growth rate | 7.9% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 21 Oct 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 11/30/2026 | 95 | 12 | 23 | 19 | 4 |
| 11/30/2025 | 87 | 7 | N/A | 11 | 4 |
| 11/30/2024 | 83 | 2 | N/A | 7 | 4 |
| 8/31/2024 | 84 | -3 | -4 | -1 | N/A |
| 5/31/2024 | 83 | -7 | -4 | -1 | N/A |
| 2/29/2024 | 78 | -18 | -6 | -4 | N/A |
| 11/30/2023 | 82 | -24 | -7 | -6 | N/A |
| 8/31/2023 | 80 | -29 | -7 | -7 | N/A |
| 5/31/2023 | 80 | -36 | -16 | -15 | N/A |
| 2/28/2023 | 81 | -49 | -14 | -12 | N/A |
| 11/30/2022 | 80 | -47 | -16 | -15 | N/A |
| 8/31/2022 | 77 | -49 | -19 | -18 | N/A |
| 5/31/2022 | 74 | -51 | -19 | -18 | N/A |
| 2/28/2022 | 73 | -35 | -18 | -18 | N/A |
| 11/30/2021 | 70 | -32 | -18 | -18 | N/A |
| 8/31/2021 | 70 | -27 | -15 | -15 | N/A |
| 5/31/2021 | 66 | -25 | -12 | -12 | N/A |
| 2/28/2021 | 66 | -24 | -14 | -14 | N/A |
| 11/30/2020 | 66 | -23 | -14 | -14 | N/A |
| 8/31/2020 | 63 | -24 | -11 | -10 | N/A |
| 5/31/2020 | 65 | -18 | -5 | -5 | N/A |
| 2/29/2020 | 64 | -16 | -13 | -12 | N/A |
| 11/30/2019 | 63 | -12 | -7 | -3 | N/A |
| 8/31/2019 | 61 | -7 | -21 | 2 | N/A |
| 5/31/2019 | 58 | -5 | -26 | -3 | N/A |
| 2/28/2019 | 52 | -4 | -18 | 4 | N/A |
| 11/30/2018 | 45 | -5 | -19 | 0 | N/A |
| 8/31/2018 | 41 | -7 | -1 | -1 | N/A |
| 5/31/2018 | 36 | -9 | N/A | -3 | N/A |
| 2/28/2018 | 35 | -15 | N/A | 0 | N/A |
| 11/30/2017 | 33 | -14 | N/A | 2 | N/A |
| 8/31/2017 | 33 | -11 | N/A | 3 | N/A |
| 5/31/2017 | 28 | -8 | N/A | 3 | N/A |
| 2/28/2017 | 28 | -1 | N/A | 4 | N/A |
| 11/30/2016 | 28 | 0 | N/A | 2 | N/A |
| 8/31/2016 | 27 | 1 | N/A | 2 | N/A |
| 5/31/2016 | 27 | 1 | N/A | 4 | N/A |
| 2/29/2016 | 25 | 2 | N/A | 5 | N/A |
| 11/30/2015 | 23 | 1 | N/A | 5 | N/A |
| 8/31/2015 | 18 | -2 | N/A | 1 | N/A |
| 5/31/2015 | 12 | -6 | N/A | 0 | N/A |
| 2/28/2015 | 8 | -6 | N/A | -4 | N/A |
| 11/30/2014 | 6 | -9 | N/A | -7 | N/A |
| 8/31/2014 | 5 | -9 | N/A | -6 | N/A |
| 5/31/2014 | 7 | -7 | N/A | -6 | N/A |
| 2/28/2014 | 7 | -9 | N/A | -6 | N/A |
| 11/30/2013 | 7 | -4 | N/A | -7 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TQ80 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).
Earnings vs Market: TQ80 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: TQ80 is expected to become profitable in the next 3 years.
Revenue vs Market: TQ80's revenue (7.9% per year) is forecast to grow faster than the German market (5.7% per year).
High Growth Revenue: TQ80's revenue (7.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if TQ80's Return on Equity is forecast to be high in 3 years time